![Thomas Needham](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Thomas Needham
Director/Board Member at
RENOVACOR, INC.
Profile
Thomas E.
Needham is the founder of Synthesis Capital, founded in 2007, where the title held was Principal from 2007 to 2012.
Current jobs include Chairman at Renovacor Holdings, Inc. since 2020; Chairman at Basking Biosciences, Inc.; Managing Director at Broadview Ventures Inc since 2018; Independent Director at Renovacor, Inc. since 2019; and Managing Director at LongView Ventures LLC since 2019.
Former jobs include President, Chief Executive Officer & Director at Spear Therapeutics Ltd.; President & Director at Trident Pharmaceuticals, Inc.; Director at Prexa Pharmaceuticals, Inc.; Director at Kantum Pharma, Inc.; Principal at Advent International LP from 2003 to 2007; Principal at ImmuLogic Pharmaceutical Corp.; Vice President at GPC Biotech AG; Chief Business Officer at Merrimack Pharmaceuticals, Inc. from 2017 to 2018; Vice President at GPC Biotech, Inc.; and Senior Vice President-Business Development at C4 Therapeutics, Inc. from 2016 to 2017.
Education includes an undergraduate degree from Bowdoin College in 1987 and an MBA from F.W.
Olin Graduate School of Business in 1992.
Thomas Needham active positions
| Companies | Position | Start |
|---|---|---|
| RENOVACOR, INC. | Director/Board Member | 01/08/2019 |
Basking Biosciences, Inc.
 Basking Biosciences, Inc. BiotechnologyHealth Technology Develops reversible thrombolytic therapy | Chairman | - |
Renovacor Holdings, Inc.
 Renovacor Holdings, Inc. BiotechnologyHealth Technology Develops transformative gene therapy | Chairman | 01/01/2020 |
Broadview Ventures, Inc.
 Broadview Ventures, Inc. Investment ManagersFinance Broadview Ventures invests in companies located across the globe, primarily in North America, Europe and Israel. The firm targets companies operating in the fields of healthcare and technology sectors. It provides financing for seed and early-stage capital requirements. The firm makes follow-on investments. | Private Equity Investor | 01/03/2018 |
LongView Ventures LLC
 LongView Ventures LLC Investment ManagersFinance LongView Ventures invests in companies located in the United States. The firm focuses on the clinical-stage companies. It provides financing for early and later stage capital requirements. | Private Equity Investor | 01/01/2019 |
Former positions of Thomas Needham
| Companies | Position | End |
|---|---|---|
| MERRIMACK PHARMACEUTICALS | Corporate Officer/Principal | 01/03/2018 |
| C4 THERAPEUTICS, INC. | Corporate Officer/Principal | 01/06/2017 |
Advent International LP
 Advent International LP Investment ManagersFinance Advent invests in companies located across the globe. The firm targets companies operating in the fields of business & financial services, healthcare, industrial and technology services. It provides financing for leveraged buyout, recapitalizations, growth and public to private transactions. It also acquires majority and minority ownership. | Private Equity Investor | 01/05/2007 |
GPC Biotech AG
 GPC Biotech AG Miscellaneous Commercial ServicesCommercial Services Discovers, develops and commercializes new anticancer drugs | Corporate Officer/Principal | 01/05/2003 |
| ░░░░░░░░░ ░░░░░░░░░░░░░░ ░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Training of Thomas Needham
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
63
1st degree connections
18
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 18 |
|---|---|
Advent International LP
Advent International LP Investment ManagersFinance Advent invests in companies located across the globe. The firm targets companies operating in the fields of business & financial services, healthcare, industrial and technology services. It provides financing for leveraged buyout, recapitalizations, growth and public to private transactions. It also acquires majority and minority ownership. | Finance |
ImmuLogic Pharmaceutical Corp.
 ImmuLogic Pharmaceutical Corp. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Trident Pharmaceuticals, Inc.
 Trident Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops novel biologics for the treatment of autoimmune disorders | Health Technology |
Prexa Pharmaceuticals, Inc.
 Prexa Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops oral small molecule monoamine reuptake inhibitors | Health Technology |
GPC Biotech AG
GPC Biotech AG Miscellaneous Commercial ServicesCommercial Services Discovers, develops and commercializes new anticancer drugs | Commercial Services |
Merrimack Pharmaceuticals, Inc.
 Merrimack Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes drugs for the treatment of immunological & autoimmune diseases and cancer | Health Technology |
GPC Biotech, Inc.
 GPC Biotech, Inc. Drugstore ChainsRetail Trade Develops anticancer drugs | Retail Trade |
Bowdoin College
 Bowdoin College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Spear Therapeutics Ltd.
 Spear Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Develops cancer treatment drugs | Health Technology |
Broadview Ventures, Inc.
Broadview Ventures, Inc. Investment ManagersFinance Broadview Ventures invests in companies located across the globe, primarily in North America, Europe and Israel. The firm targets companies operating in the fields of healthcare and technology sectors. It provides financing for seed and early-stage capital requirements. The firm makes follow-on investments. | Finance |
Synthesis Capital
 Synthesis Capital Investment ManagersFinance Synthesis Capital invests in US and European-based companies. The firm targets companies operating in the fields of bio-pharmaceutical and medical technology sectors. It provides financing for seed, early and late stage capital requirements. | Finance |
F.W. Olin Graduate School of Business
 F.W. Olin Graduate School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
C4 Therapeutics, Inc.
 C4 Therapeutics, Inc. BiotechnologyHealth Technology Develops targeted protein degradation therapeutics for the treatment of cancer | Health Technology |
Kantum Pharma, Inc.
 Kantum Pharma, Inc. Miscellaneous Commercial ServicesCommercial Services Develops novel and receptor antagonist-based therapeutics for AKI diagnostic tests | Commercial Services |
Renovacor Holdings, Inc.
Renovacor Holdings, Inc. BiotechnologyHealth Technology Develops transformative gene therapy | Health Technology |
LongView Ventures LLC
LongView Ventures LLC Investment ManagersFinance LongView Ventures invests in companies located in the United States. The firm focuses on the clinical-stage companies. It provides financing for early and later stage capital requirements. | Finance |
Basking Biosciences, Inc.
Basking Biosciences, Inc. BiotechnologyHealth Technology Develops reversible thrombolytic therapy | Health Technology |
Renovacor, Inc.
 Renovacor, Inc. BiotechnologyHealth Technology Engages in research and development for precision gene therapies and genetically driven cardiovascular diseases | Health Technology |
- Stock Market
- Insiders
- Thomas Needham
